PCA
NUVB icon

Pallas Capital Advisors’s Nuvation Bio NUVB Stock Holding History

Pallas Capital Advisors’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$189K Sell
44,082
-1,691
-4% -$9.42K 0.01% 776
2025
Q4 		$410K Hold
45,773
– – 0.01% 592
2025
Q3 		$169K Buy
45,773
+3,454
+8% +$9.41K 0.01% 800
2025
Q2 		$82.5K Buy
42,319
+22,040
+109% +$45.9K ﹤0.01% 803
2025
Q1 		$35.7K Buy
20,279
+3,263
+19% +$7.43K ﹤0.01% 736
2024
Q4 		$45.3K Buy
17,016
+1,082
+7% +$2.79K ﹤0.01% 575
2024
Q3 		$36.6K Buy
15,934
+2,577
+19% +$7.86K ﹤0.01% 593
2024
Q2 		$42.5K Buy
13,357
+1,788
+15% +$5.46K ﹤0.01% 497
2024
Q1 		$42.1K Buy
11,569
+1,569
+16% +$3.01K ﹤0.01% 427
2023
Q4 		$15.1K Sell
10,000
-284
-3% -$365 ﹤0.01% 355
2023
Q3 		$10.3K Hold
10,284
– – ﹤0.01% 344
2023
Q2 		$17.5K Buy
10,284
+284
+3% +$483 ﹤0.01% 258
2023
Q1 		$17.5K Hold
10,000
– – ﹤0.01% 268
2022
Q4 		$23.6K Hold
10,000
– – ﹤0.01% 266
2022
Q3 		$21K Hold
10,000
– – ﹤0.01% 250
2022
Q2 		$31K Hold
10,000
– – ﹤0.01% 224
2022
Q1 		$55K Buy
+10,000
New +$56.2K 0.01% 231

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Pallas Capital Advisors's NUVB Position: Q1 2026 in Review

Pallas Capital Advisors reduced its Nuvation Bio (NUVB) stake by 3.7% in Q1 2026, selling an estimated $9.42K and leaving 44,082 shares worth $189K. The position accounts for 0.01% of the portfolio, ranked #776.

Pallas Capital Advisors first reported a position in NUVB in Q1 2022 and has held it in 17 quarters since. The position peaked at $410K in Q4 2025. 231 funds tracked by Wall St. Rank hold NUVB as of Q1 2026.

  • Pallas Capital Advisors held 44,082 shares of Nuvation Bio worth $189K as of Q1 2026.
  • Pallas Capital Advisors sold 1,691 Nuvation Bio shares in Q1 2026, an estimated $9.42K.
  • Nuvation Bio made up 0.01% of Pallas Capital Advisors's portfolio in Q1 2026, its #776 holding.
  • Pallas Capital Advisors first reported a position in Nuvation Bio in Q1 2022 and has held it in 17 quarters since.
  • Pallas Capital Advisors's Nuvation Bio position peaked at $410K in Q4 2025.
  • 231 funds tracked by Wall St. Rank held Nuvation Bio as of Q1 2026.

Based on Pallas Capital Advisors's 13F filing for Q1 2026, filed 21 Apr 2026.